Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1720893 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.79Day −1.20%Mkt cap $24M1Y −44.6%Off 52W high −90.2%Vol (1Y) 145.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,105 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest13.1% of sh out |
| Days to cover1.6d |
| 13F net flow (QoQ)+0.66% |
| Top-10 13F concentration92.3% |
| Next report (est.)2026-08-15 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$680,000 |
| Earnings (TTM)-$75.3M |
| Net margin−10887.4% |
| Sales growth 3Y19.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−50.5% |
| 1Y−44.6% |
| 3Y−99.5% |
| 5Y−99.8% |
| Since incept. (ann.)−47.4% |
Total return through 2026-07-30 · series begins 2018-03-08. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)145.0% |
| Ann. volatility (3Y)135.9% |
| Sharpe (1Y)0.12 |
| Sharpe (3Y)−0.66 |
| Max drawdown (1Y)−88.3% |
| Max drawdown (3Y)−99.5% |
| Beta (3Y vs SPY)0.15 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1.9M | $3M | 7.15% | +5.5% |
| ARMISTICE CAPITAL, LLC | 1.9M | $3M | 7.05% | new |
| OAKTREE CAPITAL MANAGEMENT LP | 241,188 | $323,193 | 0.89% | +0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 230,168 | $308,725 | 0.85% | +11.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 207,339 | $277,834 | 0.77% | new |
| JONES FINANCIAL COMPANIES LLLP | 131,789 | $166,054 | 0.49% | −4.3% |
| Man Group plc | 96,473 | $129,274 | 0.36% | +69.8% |
| STATE STREET CORP | 92,118 | $123,438 | 0.34% | +45.7% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | −$0.54 | — | $206,000 | +22.6% |
| 2025-12-31 | 2026-03-27 | — | — | $256,000 | −30.1% |
| 2025-09-30 | 2025-11-12 | −$2.18 | — | $98,000 | −54.2% |
| 2025-06-30 | 2025-08-12 | −$2.45 | — | $120,000 | −89.1% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-15 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
